Biospecifics Technologies (BSTC) Announces Significant Data from CCH Phase 2 as Human Lipoma Treatment
Tweet Send to a Friend
BioSpecifics Technologies Corp. (Nasdaq: BSTC) announced positive, statistically significant top-line results from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
